European Case Law Identifier: | ECLI:EP:BA:2013:J001712.20131113 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 13 November 2013 | ||||||||
Case number: | J 0017/12 | ||||||||
Application number: | 03781836.6 | ||||||||
IPC class: | A61K 38/11 A61P 13/00 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN | ||||||||
Applicant name: | Allergan, Inc. Third party: Ferring BV |
||||||||
Opponent name: | - | ||||||||
Board: | 3.1.01 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Reversal of entry of applicant in register (yes) Continuation of appeal proceedings with wrong parties (no) Referral to the Enlarged Board of Appeal - (no) |
||||||||
Catchwords: |
The transfer of a European patent application may not be recorded in the European Patent Register at a time when proceedings for the grant of the application are stayed under Rule 14(1) EPC. |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/j120017eu1.html
Date retrieved: 17 May 2021